Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Klabzuba Cancer Center at Harris Methodist Fort Worth Hospital
mi
from
Fort Worth, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Klabzuba Cancer Center at Harris Methodist Fort Worth Hospital
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Texas Oncology, PA at Texas Cancer Center - Sherman
mi
from
Sherman, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Texas Oncology, PA at Texas Cancer Center - Sherman
mi
from
Sherman, TX
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
mi
from
Sugar Land, TX
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Sandra L. Maxwell Cancer Center
mi
from
Cedar City, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Sandra L. Maxwell Cancer Center
mi
from
Cedar City, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
mi
from
Murray, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
mi
from
Ogden, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
mi
from
Ogden, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Utah Valley Regional Medical Center - Provo
mi
from
Provo, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Utah Valley Regional Medical Center - Provo
mi
from
Provo, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Dixie Regional Medical Center - East Campus
mi
from
Saint George, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Dixie Regional Medical Center - East Campus
mi
from
Saint George, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Utah Cancer Specialists at UCS Cancer Center
mi
from
Salt Lake City, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Utah Cancer Specialists at UCS Cancer Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
LDS Hospital
mi
from
Salt Lake City, UT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Fletcher Allen Health Care - University Health Center Campus
mi
from
Burlington, VT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Fletcher Allen Health Care - University Health Center Campus
mi
from
Burlington, VT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Community Cancer Center at Rutland Regional Medical Center
mi
from
Rutland, VT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Community Cancer Center at Rutland Regional Medical Center
mi
from
Rutland, VT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
INOVA Alexandria Hospital
mi
from
Alexandria, VA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
INOVA Alexandria Hospital
mi
from
Alexandria, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Danville Regional Medical Center
mi
from
Danville, VA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Danville Regional Medical Center
mi
from
Danville, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Sentara Cancer Institute at Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Sentara Cancer Institute at Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Harrison Medical Center
mi
from
Bremerton, WA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Harrison Medical Center
mi
from
Bremerton, WA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
St. Francis Hospital
mi
from
Federal Way, WA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
St. Francis Hospital
mi
from
Federal Way, WA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Good Samaritan Cancer Center
mi
from
Puyallup, WA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Good Samaritan Cancer Center
mi
from
Puyallup, WA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Franciscan Cancer Center at St. Joseph Medical Center
mi
from
Tacoma, WA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Franciscan Cancer Center at St. Joseph Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
CCOP - Northwest
mi
from
Tacoma, WA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
MultiCare Regional Cancer Center at Tacoma General Hospital
mi
from
Tacoma, WA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
MultiCare Regional Cancer Center at Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
West Virginia University Health Sciences Center - Charleston
mi
from
Charleston, WV
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
West Virginia University Health Sciences Center - Charleston
mi
from
Charleston, WV
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Theda Care Cancer Institute
mi
from
Appleton, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Theda Care Cancer Institute
mi
from
Appleton, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Community Memorial Hospital Cancer Care Center
mi
from
Menomonee Falls, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Community Memorial Hospital Cancer Care Center
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Columbia Saint Mary's Hospital - Ozaukee
mi
from
Mequon, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Columbia Saint Mary's Hospital - Ozaukee
mi
from
Mequon, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Veterans Affairs Medical Center - Milwaukee
mi
from
Milwaukee, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Veterans Affairs Medical Center - Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
All Saints Cancer Center at Wheaton Franciscan Healthcare
mi
from
Racine, WI
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
All Saints Cancer Center at Wheaton Franciscan Healthcare
mi
from
Racine, WI
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
British Columbia Cancer Agency - Centre for the Southern Interior
mi
from
Kelowna,
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
British Columbia Cancer Agency - Centre for the Southern Interior
mi
from
Kelowna,
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Kaiser Permanente Medical Center - Rancho Cordova
mi
from
Rancho Cordova, CA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Kaiser Permanente Medical Center - Rancho Cordova
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
General Robert Huyser Cancer Center at David Grant Medical Center
mi
from
Travis Air Force Base, CA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
General Robert Huyser Cancer Center at David Grant Medical Center
mi
from
Travis Air Force Base, CA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated:  3/14/2018
Regions Hospital - Cancer Care Center
mi
from
Saint Paul, MN
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients With Favorable-Risk Prostate Cancer
Status: Enrolling
Updated: 3/14/2018
Regions Hospital - Cancer Care Center
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
INST 0816: Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
Status: Enrolling
Updated:  3/14/2018
University of New Mexico Cancer Center @ Lovelace Medical Center
mi
from
Albuquerque, NM
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
INST 0816: Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
Status: Enrolling
Updated: 3/14/2018
University of New Mexico Cancer Center @ Lovelace Medical Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
INST 0816: Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
Status: Enrolling
Updated:  3/14/2018
Universtiy of New Mexico Cancer Center
mi
from
Albuquerque, NM
Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
INST 0816: Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight
Status: Enrolling
Updated: 3/14/2018
Universtiy of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Status: Enrolling
Updated:  3/14/2018
Massachusetts General Hospital
mi
from
Boston, MA
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
Status: Enrolling
Updated: 3/14/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
Phase 2 Study of AZD2171 (NSC 732208) in Combination With Pemetrexed in Relapsed Non-Small Cell Lung Cancer (NOS: 10029514)
Status: Enrolling
Updated:  3/15/2018
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
Phase 2 Study of AZD2171 (NSC 732208) in Combination With Pemetrexed in Relapsed Non-Small Cell Lung Cancer (NOS: 10029514)
Status: Enrolling
Updated: 3/15/2018
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
Phase 2 Study of AZD2171 (NSC 732208) in Combination With Pemetrexed in Relapsed Non-Small Cell Lung Cancer (NOS: 10029514)
Status: Enrolling
Updated:  3/15/2018
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer
Phase 2 Study of AZD2171 (NSC 732208) in Combination With Pemetrexed in Relapsed Non-Small Cell Lung Cancer (NOS: 10029514)
Status: Enrolling
Updated: 3/15/2018
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Evaluation of Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Status: Enrolling
Updated:  3/15/2018
Memorial Sloan-Kettering
mi
from
New York, NY
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Evaluation of Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Status: Enrolling
Updated: 3/15/2018
Memorial Sloan-Kettering
mi
from
New York, NY
Click here to add this to my saved trials
Study of Everolimus (RAD001) in Combination With Lenalidomide
Phase I Study of Everolimus (RAD001) in Combination With Lenalidomide in Patients With Advanced Solid Malignancies Enriched for Renal Cell Carcinoma
Status: Enrolling
Updated:  3/15/2018
Grady Health System
mi
from
Atlanta, GA
Study of Everolimus (RAD001) in Combination With Lenalidomide
Phase I Study of Everolimus (RAD001) in Combination With Lenalidomide in Patients With Advanced Solid Malignancies Enriched for Renal Cell Carcinoma
Status: Enrolling
Updated: 3/15/2018
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Everolimus (RAD001) in Combination With Lenalidomide
Phase I Study of Everolimus (RAD001) in Combination With Lenalidomide in Patients With Advanced Solid Malignancies Enriched for Renal Cell Carcinoma
Status: Enrolling
Updated:  3/15/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Study of Everolimus (RAD001) in Combination With Lenalidomide
Phase I Study of Everolimus (RAD001) in Combination With Lenalidomide in Patients With Advanced Solid Malignancies Enriched for Renal Cell Carcinoma
Status: Enrolling
Updated: 3/15/2018
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials